User uShare Login | Register
Login
Register

Along with posting photos, videos, and stories, your uShare account lets you post Classified Ads, recipes on What's For Dinner, and Announcements.


73° View Weather Current Conditions Sioux Falls Change Location
Set Weather Options

RADAR LOCATION

TEMPERATURE LOCATION

Share your Photos, Videos, and Stories on uShare! Click here to get started.

Severe storms possible Sunday night: Click here for details.

 

News

[0] My Saved Articles
Back to all news

Business

Find local businesses
on the KELO Pages!

 

Most Popular Today


Sanford Research Secures Two NIH Grants

August 28, 2013, 2:08 PM

Sanford Research Secures Two NIH Grants
SIOUX FALLS, SD -

A pair from Sanford Research has received separate grants from the National Institutes of Health (NIH) totaling more than $2.6 million for studies involving genomic proteins and a cancer-killing drug.

Kyle J. Roux, PhD, earned a five-year, $1.52 million award from the NIH’s National Institute of General Medical Sciences (NIGMS) for his project titled “Developing methods for proximity-dependent protein labeling.”

Keith Miskimins, PhD, and his study, “Molecular mechanisms by which the diabetic drug metformin kills cancer cells,” will receive more than $1.18 million over four years from the NIH’s National Cancer Institute (NCI).

Last year, Dr. Roux unveiled a new way to identify the proximity and interactions between proteins in living cells called BioID.  The system provides insight into the underlying mechanisms of disease. His grant will allow him to further develop BioID and advance the rate at which scientists characterize proteins and their interactions, which helps in the design of therapies for human disease.

“With the human genome sequenced, we have now shifted our attention toward the challenging task of characterizing the protein products of that genome,” said Dr. Roux. “The results of this study will provide the research community with the fundamental knowledge of the capabilities of BioID.”

Dr. Miskimins’ study will explore the molecular and cellular mechanisms by which metformin, a drug used to treat type 2 diabetes, kills cancer cells. In cultured cells and animal models, metformin has been found to kill cancer cells and slow tumor growth, but the drug behaves differently when other compounds are present or nutrient availability changes.

“We want to understand how the combinations of other compounds and nutrients affect cancer cells at the molecular level and provide a rationale for how they might be used clinically,” said Dr. Miskimins. “While this study will primarily focus on breast cancer, the results could be applicable to many types of cancer.”

This is the third NIH grant for Sanford Research this summer.  In July, Michael Kruer, MD, a Sanford pediatric neurologist and neurogeneticist, was awarded $860,000 in NIH funding to further genetic research on juvenile Parkinson's disease and dystonia.

The NIH, a part of the U.S. Department of Health and Human Services Policy, is the nation’s medical research agency.

Disclaimer: This story has been reviewed but not edited or fact-checked. Views of the author are not necessarily those of this station, its owners, officers, agents or employees.

 

Previous Story

Next Story




Sponsored

 


View business

You may also like

Presidential Proposal Would Expand Overtime Pay

6/30/2015 7:08 AM

Obama is unveiling a proposal to require overtime pay for workers who earn up to $970 per week, up from the current $455 threshold.

Full Story
Moe's Southwest Grill Selects Sioux Falls Location

6/29/2015 12:41 PM

You will soon have a new option for chips and salsa, salads and tacos in Sioux Falls.

Full Story
New Outdoor Venue For Falls Park West

6/29/2015 5:07 PM

Mayor Mike Huether's Capital Improvement Plan includes $2.5 million for the Levitt project.

Full Story | Watch
New Laws Bring Changes To Commercial Driver's Licenses

7/1/2015 6:52 AM

The new regulations raise the minimum age to apply for a commercial driver's license from 16 to 18.

Full Story
Greek Banks Closed, ATM Withdrawals Limited

6/29/2015 7:58 AM

French President Francois Hollande says France has "nothing to fear" from an eventual Greek departure from the eurozone.

Full Story


Events